Status
Conditions
Treatments
About
Active metropolitan area surveillance for hospital admissions related to invasive infection with Neisseria meningitidis will be conducted at the 12 centers in the IMPACT network in collaboration with Public Health officials, local infection specialists and infection control practitioners during the interval from January 1, 2016 to December 31, 2022.
Full description
The objectives are 3-fold, including:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:Neisseria meningitidis isolated or detected by PCR from a normally sterile body site or fluid, such as blood, CSF, joint fluid, pleural, peritoneal, pericardial fluid or tissue biopsy -
Exclusion Criteria:patients diagnosed based only on
400 participants in 1 patient group
Loading...
Central trial contact
Marie Adele Davis; Melanie Laffin Thibodeau
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal